Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2012
08/28/2012CA2398590C Cells for drug discovery
08/28/2012CA2392943C Chemistry system for a clinical analyzer
08/28/2012CA2390152C Enhanced transgene expression by co-expression with a suppressor of post-transcriptional gene silencing (ptgs)
08/28/2012CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/28/2012CA2383880C Methods and compositions for detecting pathological events
08/28/2012CA2284110C An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
08/23/2012WO2012112977A1 Laser speckle microrheometer for measuring mechanical properties of biological tissue
08/23/2012WO2012112958A2 High-throughput assays to probe leukemia within the stromal niche
08/23/2012WO2012112865A2 Compositions and methods to prevent cell transformation and cancer metastasis
08/23/2012WO2012112737A2 Alzheimer's disease cellular model for diagnostic and therapeutic development
08/23/2012WO2012112697A2 Method and system to digitize pathology specimens in a stepwise fashion for review
08/23/2012WO2012112609A2 Substrates and methods for staining live cells
08/23/2012WO2012112563A2 Methods and compositions for the target-localized anchoring of detectable label
08/23/2012WO2012112443A2 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
08/23/2012WO2012112440A2 Fluorescent potassium ion sensors
08/23/2012WO2012112315A2 Methods for diagnosis of kawasaki disease
08/23/2012WO2012112256A2 Target odor detection and security apparatus
08/23/2012WO2012112048A1 Modulators of prr and gpcr signalling
08/23/2012WO2012112013A2 A marker comprising anti-ck8/18 complex autoantibody and its use for diagnosing cancer
08/23/2012WO2012111852A1 Therapeutic agent for vertebral body fracture and method for evaluating same
08/23/2012WO2012111842A1 Amyloid protein oligomer binding aptamer
08/23/2012WO2012111775A1 Labeling agent for post-translational modification analysis of serine and threonine
08/23/2012WO2012111687A1 Manufacturing method for streptavidin-bonded magnetic particles
08/23/2012WO2012111686A1 Manufacturing method for streptavidin-bonded magnetic particles
08/23/2012WO2012111685A1 Streptavidin-bonded magnetic particles and manufacturing method for same
08/23/2012WO2012111469A1 Device for checking state of liquid, and liquid tank with the device
08/23/2012WO2012111328A1 Urine test sheet
08/23/2012WO2012111001A2 Optical sensor with enhanced sensitivity
08/23/2012WO2012110965A1 Device for analysing the internal atmosphere of the casing of an electric rotating machine
08/23/2012WO2012110964A1 Method and device for detecting and/or dosing organic compounds in the air
08/23/2012WO2012110922A1 Measurement chip, microfluidic device and method
08/23/2012WO2012110878A2 Method of diagnosing cancer and diagnosis kit using measurement of nk cell activity
08/23/2012WO2012110833A2 Fluorescence modulators
08/23/2012WO2012110824A1 Binding agents with specificity for a nucleic acid modification
08/23/2012WO2012110740A1 Fabric testing machine designed in particular to determine the acoustic properties of a fabric
08/23/2012WO2012110693A1 Method for improving quality and functionality of filter paper suitable for collecting biological samples
08/23/2012WO2012110593A1 Vancomycin analysis
08/23/2012WO2012110500A1 Means and methods for improvement of synaptic dysfunction disorders
08/23/2012WO2012110483A1 Means and methods for diagnosing pregnancy complications based on sflt1 and gdf-15
08/23/2012WO2012110426A1 Neuronal network based biosensor
08/23/2012WO2012110385A1 Method and apparatus for diagnosing the electrical contacting of an exhaust gas sensor
08/23/2012WO2012110253A2 Exosomal biomarkers for cardiovascular events
08/23/2012WO2012110148A1 Automated insertion of a contact rod into a metallurgical probe
08/23/2012WO2012110099A1 Determination of exosomal biomarkers for predicting cardiovascular events
08/23/2012WO2012110024A2 Diagnostic kit and method for examining a human patient sample for the presence of antibodies specific to neuromyelitis optica
08/23/2012WO2012109977A1 Protein complex and spectrum thereof and uses thereof in disease diagnosis, progress evaluation and efficacy evaluation
08/23/2012WO2012109802A1 Immunodominant antigen of aspergillus and use thereof
08/23/2012WO2012109761A1 Raman scattering nanoprobes
08/23/2012WO2012109743A1 Methods and compositions relating to coagulation assays
08/23/2012WO2012094251A3 Device and method for sampling bodily fluid for medical analytes in ultra low concentrations
08/23/2012WO2012092529A3 Protein biomarkers of recurrent breast cancer
08/23/2012WO2012092281A3 Quantitation of insulin by mass spectrometry
08/23/2012WO2012091465A3 Monoclonal antibodies to serum amyloid a, and hybridoma cells producing same
08/23/2012WO2012085267A3 Method and system for measuring the composition of a multiphase well sample
08/23/2012WO2012081928A3 Method for detecting methylation of the bowel-cancer-specific methylation marker gpm6a gene in order to diagnose bowel cancer
08/23/2012WO2012079010A3 Improved method and kit for determining severity and progression of periodontal disease
08/23/2012WO2012078313A3 Gb1 peptidic libraries and compounds, and methods of screening the same
08/23/2012WO2012078270A3 Efficient and effective supplement screening for the development of chemically defined media in cell culture
08/23/2012WO2012076137A3 Consumable for measuring an analyte concentration of a body fluid sample, reader for reading an optical data storage of such a consumable and measuring system
08/23/2012WO2012075075A3 Methods and systems for spatially identifying abnormal cells
08/23/2012WO2012071578A3 Pharmacology bioassays for drug discovery, toxicity evaluation and in vitro cancer research using a 3d nano-cellulose scaffold and living tissue
08/23/2012WO2012071471A3 Biosensing systems for measurement of lactose
08/23/2012WO2012070014A3 Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells
08/23/2012WO2012069941A3 Vaginal indicator to detect biomarkers of good health
08/23/2012WO2012067450A3 Efemp1 gene as a diagnostic marker for prostate cancer
08/23/2012WO2012061719A3 Dna origami devices
08/23/2012WO2012040226A3 Gene expression in n-cadherin overexpressing prostate cancers and their controls
08/23/2012WO2012038470A3 Method for the detection of fat-soluble vitamins
08/23/2012WO2012037199A3 Methods for diagnosis and prognosis of inflammatory bowel disease using cytokine profiles
08/23/2012WO2012032536A3 System and method for non-invasive determination of hemoglobin concentration in blood
08/23/2012WO2012026743A3 Labeling agent and amino acid sequence using same, and method for performing simultaneous quantitative analysis of multiple proteins
08/23/2012WO2012008747A3 Skin diagnosis method and kit
08/23/2012WO2012007931A3 Silver electrode catalyst
08/23/2012WO2011143656A3 Compositions and methods of identifying tumor specific neoantigens
08/23/2012WO2011122857A3 Composition for predicting prognosis of breast cancer, and kit containing same
08/23/2012US20120216320 Method for modulating plant growth, nucleic acid molecules and polypeptides encoded thereof useful as modulating agent
08/23/2012US20120216304 Humanized animals via tissue engineering and uses thereof
08/23/2012US20120216302 Methods and assays for treating subjects with shank3 deletion, mutation or reduced expression
08/23/2012US20120215514 Systems and methods for detecting biological features
08/23/2012US20120215462 System and methods for processing analyte sensor data
08/23/2012US20120215461 System and methods for processing analyte sensor data
08/23/2012US20120214971 Novel anti-il13 antibodies and uses thereof
08/23/2012US20120214875 Phenoxybenzamine assay
08/23/2012US20120214870 Methods for diagnosis and treatment of chronic fatigue syndrome
08/23/2012US20120214868 Modified L-Nucleic Acid
08/23/2012US20120214861 Methods and compositions for treating neurological disease
08/23/2012US20120214831 Method for determination of sensitivity to anti-cancer agent
08/23/2012US20120214830 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors in hepatocellular carcinoma
08/23/2012US20120214829 Molecular Predictors of Therapeutic Response to Specific Anti-Cancer Agents
08/23/2012US20120214828 Determining sensitivity of cells to b-raf inhibitor treatment by detecting kras mutation and rtk expression levels
08/23/2012US20120214737 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2
08/23/2012US20120214710 Method of predicting response to thalidomide in multiple myeloma patients
08/23/2012US20120214709 Isolating biological modulators from biodiverse gene fragment libraries
08/23/2012US20120214687 Baff receptor (bcma), an immunoregulatory agent
08/23/2012US20120214685 Methods and compositions for diagnosis of ectopic pregnancy
08/23/2012US20120214684 Compositions and methods for detecting and treating prostate carcinoma
08/23/2012US20120214683 Methods of targeting baff
08/23/2012US20120214257 Reagent Kit for Determining an Analyte in a Sample by Agglutination
08/23/2012US20120214256 Method of analysis of genetic markers
08/23/2012US20120214245 Systems and methods for breast cancer detection and risk assessment
1 ... 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 ... 3937